Not applicableTemporarily pausedNCT00636753What this trial is testingAntipsychotics and Metabolic SyndromeWho this might be right forMetabolic Syndrome Glostrup University Hospital, Copenhagen 60
Large-scale testing (Phase 3)UnknownNCT02907437What this trial is testingMinocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in SchizophreniaWho this might be right forSchizophrenia Beer Yaakov - Ness Ziona Mental Health Center 40
Large-scale testing (Phase 3)Study completedNCT00412373What this trial is testingEvaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.Who this might be right forSchizoaffective DisorderPsychotic Disorder Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 307
Large-scale testing (Phase 3)WithdrawnNCT02212613What this trial is testingBrexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and IrritabilityWho this might be right forMajor Depressive Disorder and Irritability Otsuka Pharmaceutical Development & Commercialization, Inc.
Not applicableStudy completedNCT00206960What this trial is testingDopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode SchizophreniaWho this might be right forSchizophrenia Birte Glenthoj 56
Not applicableStudy completedNCT00627510What this trial is testingRoutine Plasma Level Determination to Compare Actual vs Expected Plasma Levels at Psychiatric Inpatient AdmissionWho this might be right forDepressionAffective Disorders, Psychotic Medical University Innsbruck 161
Not applicableStudy completedNCT00283517What this trial is testingA Registry of Treatment Adherence for Patients With SchizophreniaWho this might be right forSchizophreniaPsychotic Disorders Janssen-Cilag, S.A. 2,046
Post-approval studies (Phase 4)Study completedNCT00232336What this trial is testingQuetiapine for Cocaine Use and CravingsWho this might be right forCocaine-Related DisordersSubstance-Related Disorders Seattle Institute for Biomedical and Clinical Research 42
Large-scale testing (Phase 3)Study completedNCT01794429What this trial is testingTreatment of Antipsychotic-associated Obesity With a GLP-1 AnalogueWho this might be right forObesityMetabolic Syndrome XDrug-induced Obesity+1 more Bjorn H. Ebdrup 45
Large-scale testing (Phase 3)Study completedNCT05110157What this trial is testingJourney Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for SchizophreniaWho this might be right forSchizophrenia Neurocrine Biosciences 442
Large-scale testing (Phase 3)Study completedNCT00236457What this trial is testingA Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective DisorderWho this might be right forSchizophreniaPsychotic Disorders Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 629
Large-scale testing (Phase 3)Study completedNCT01192867What this trial is testingRO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)Who this might be right forSchizophrenia Hoffmann-La Roche 629
Large-scale testing (Phase 3)Ended earlyNCT01738698What this trial is testingAdjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of SchizophreniaWho this might be right forSchizophrenia Shire 4
Large-scale testing (Phase 3)Study completedNCT01244815What this trial is testingEfficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)Who this might be right forBipolar Disorder, Pediatric Organon and Co 404
Not applicableStudy completedNCT02085447What this trial is testingA Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and HomelessnessWho this might be right forPsychotic DisordersSchizophreniaSchizoaffective Disorder+2 more University Hospitals Cleveland Medical Center 30
Post-approval studies (Phase 4)Study completedNCT00231894What this trial is testingPioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With SchizophreniaWho this might be right forDiabetesSchizophreniaInsulin Resistance+1 more Nathan Kline Institute for Psychiatric Research 56
Testing effectiveness (Phase 2)WithdrawnNCT05433402What this trial is testingRepurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon CancerWho this might be right forColon Cancer Stage III Sadat City University
Post-approval studies (Phase 4)Study completedNCT00526877What this trial is testingAn Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care TreatmentWho this might be right forSchizophreniaSchizoaffective Disorders Johnson & Johnson Taiwan Ltd 31
Large-scale testing (Phase 3)Study completedNCT01716975What this trial is testingStudy of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyWho this might be right forSchizophreniaImpaired Cognition FORUM Pharmaceuticals Inc 767
Not applicableStudy completedNCT01212575What this trial is testingA Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With SchizophreniaWho this might be right forSchizophrenia AstraZeneca 186